PRESS
CONTACT
English
German Health Alliance
  • About us
    • GHA Profile
    • GHA Advisory Board
    • GHA Board of Directors
    • GHA MANAGEMENT
    • GHA SPEAKERS
    • GHA REPRESENTATIVES
    • GHA Partners Network
    • GHA BACKGROUND
  • Topics
    • GLOBAL HEALTH
    • German Global Health Award
    • GHA MEDTECH NETWORK
    • BDI-GHA Position Paper China
    • Systemic Calls for Tender
    • GREEN HOSPITAL
    • E-LEARNING: Managing Health Facilities
    • TRADE FAIRS
    • Covid-19 Information Portal
    • Position Papers | Studies | Analyses | Brochures
  • Working Committees
    • GHA Working Committees
    • Africa
    • China
    • Consulting & Architecture
    • Development Cooperation
    • Education & Training
    • East Europe & CIS
    • Global Health
    • Latin America
    • MENA
    • Medical Technology
  • Members
    • GHA MEMBERS
    • SERVICES FOR GHA MEMBERS
    • Become a GHA Member
    • Login for GHA Members
  • Solutions
  • Events
    • Overview
    • Event Calendar
  • News
Become a GHA Member
Partners

Daedalus® – Your database for registering your medical devices in compliance with country-specific requirements

Posted on February 16, 2021

The medical device market is one of the most regulated industries today. More and more country-specific regulations and laws are making it increasingly difficult for manufacturers to expand abroad.

With its unique online database Daedalus®, RegIntA GmbH from Altenstadt in the Rhine-Main area supports entrepreneurs in complying with international regulations, relieves the Regulatory Affairs departments and thus creates legal certainty for medical device manufacturers.

Daedalus® provides manufacturers with an easy-to-understand, up-to-date and country-specific overview that helps companies meet the regulatory requirements in the respective markets. Regulatory Affairs departments, which have access to the comprehensive know-how of international regulations, thus save time-consuming and cost-intensive research of their own. Errors in the critical approval phase are avoided, so that products reach the market more quickly.

Daedalus® also supports companies with change notifications and renewal applications covering the entire product cycle.

RegIntA continuously updates booked information, which clients can access 24/7 via an online portal. Maximum flexibility is offered through packages with different performance features. The countries can also be freely selected.

Currently, RegIntA is presenting a trial offer that gives all interested manufacturers the opportunity to test Daedalus® for three countries for three months free of charge: https://www.reginta.de/registration.html

Previous Post
7. “Access to Medicine Index”
Next Post
UNAIDS Director of Innovation receives prestigious Social Innovators of the Year award
  • Become a GHA Member
  • Subscribe to Newsletter
  • Press
  • Imprint
  • Data Protection
  • Contact

© 2022 by GHA – German Health Alliance

LinkedIn
Twitter
Email